A real world, retrospective, single centre study of Pomalidomide, cyclophosphamide, and dexamethasone (PCD) in relapsed/refractory multiple myeloma patients
Latest Information Update: 18 Jun 2019
At a glance
- Drugs Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 18 Jun 2019 New trial record
- 01 Jun 2019 Results assessing efficacy of pomalidomide, cyclophosphamide, and dexamethasone in relapsed myeloma patients, published in the Annals of Hematology.